Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Biogen, AbbVie once-monthly multiple sclerosis injection wins USFDA approval

      Biogen, AbbVie once-monthly multiple sclerosis injection wins USFDA approval

      savita thakur thakur30 May 2016 4:51 PM IST
      The U.S. Food and Drug Administration approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc, with a boxed...
      Government to conduct study to assess impact of FDI in pharma industry

      Government to conduct study to assess impact of FDI in pharma industry

      savita thakur thakur30 May 2016 4:51 PM IST
      NEW DELHI: The Commerce and Industry Ministry has commissioned a study to assess the impact of foreign direct investment in pharmaceutical companies...
      Strides Shasun gets USFDA nod for anti-biotic and anti-protozoal tablets

      Strides Shasun gets USFDA nod for anti-biotic and anti-protozoal tablets

      savita thakur thakur29 May 2016 6:17 PM IST
      NEW DELHI: Strides Shasun said it has received approval from the US health regulator for anti-biotic and anti-protozoal tablets Metronidazole.The...
      FDA approves new diagnostic imaging agent to detect recurrent prostate cancer

      FDA approves new diagnostic imaging agent to detect recurrent prostate cancer

      savita thakur thakur29 May 2016 6:17 PM IST
      The U.S. Food and Drug Administration approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission...
      Jubilant Life signs $180 mn outlicensing deal with Checkpoint

      Jubilant Life signs $180 mn outlicensing deal with Checkpoint

      savita thakur thakur29 May 2016 6:17 PM IST
      NEW DELHI: Drug firm Jubilant Life Sciences (JLS) announced a $180 million out-licensing pact with Checkpoint Therapeutics Inc for a family of...
      RPG Life Sciences sells biotech unit in Gujarat to Intas Pharma

      RPG Life Sciences sells biotech unit in Gujarat to Intas Pharma

      savita thakur thakur29 May 2016 6:17 PM IST
      NEW DELHI: RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business...
      Sun Pharma, Daiichi terminate transaction pacts

      Sun Pharma, Daiichi terminate transaction pacts

      savita thakur thakur28 May 2016 12:51 PM IST
      NEW DELHI: Sun Pharmaceutical Industries said the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries...
      Lupin receives EIR report from USFDA on inspection closure

      Lupin receives EIR report from USFDA on inspection closure

      savita thakur thakur28 May 2016 12:51 PM IST
      NEW DELHI: Pharma major Lupin said it has received an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep...
      AstraZeneca potassium drug delayed by manufacturing snag

      AstraZeneca potassium drug delayed by manufacturing snag

      savita thakur thakur28 May 2016 12:50 PM IST
      LONDON: AstraZeneca said U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a...
      G7 told to act on antibiotics as dreaded superbug hits U.S.

      G7 told to act on antibiotics as dreaded superbug hits U.S.

      savita thakur thakur28 May 2016 12:50 PM IST
      JAPAN/LONDON: Britain told the G7 industrial powers to do more to fight killer superbugs as the United States reported the first case in the country...
      FDA approves first buprenorphine implant for treatment of opioid dependence

      FDA approves first buprenorphine implant for treatment of opioid dependence

      savita thakur thakur27 May 2016 2:16 PM IST
      The U.S. Food and Drug Administration approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence....
      Strides Shasun gets US health regulator tentative nod for HIV treatment drug

      Strides Shasun gets US health regulator tentative nod for HIV treatment drug

      savita thakur thakur27 May 2016 2:15 PM IST
      NEW DELHI: Strides Shasun said it has received tentative approval from the US health regulator for Efavirenz tablets used in treating human...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok